Login / Signup

Current Updates in the Pharmacotherapy of Heart Failure with a Preserved Ejection Fraction.

Ranjan DahalNils NickelDebabrata MukherjeeHaider Alkhateeb
Published in: Cardiovascular & hematological disorders drug targets (2022)
EMPEROR-PRESERVED (Empagliflozin) and PRESERVED-HF (Dapagliflozin) results in the management of HFpEF look promising irrespective of diabetes status. Sacubitrilvalsartan and Empagliflozon are the only medications approved for its management as per the PARAGON-HF and EMPEROR-PRESERVED studies, respectively.
Keyphrases